vs
Indivior Pharmaceuticals, Inc.(INDV)与PROGRESS SOFTWARE CORP(PRGS)财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是PROGRESS SOFTWARE CORP的1.4倍($357.0M vs $252.7M),Indivior Pharmaceuticals, Inc.净利率更高(28.9% vs 10.2%,领先18.7%),PROGRESS SOFTWARE CORP自由现金流更多($59.9M vs $-245.0M)
Indivior是一家全球专科制药企业,专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案,核心市场覆盖北美与欧洲,旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
Progress Software是全球领先的企业级软件服务商,主营应用开发平台、数据连接工具、数字体验解决方案等产品,服务覆盖金融、医疗、制造、零售等多行业的全球企业客户,助力客户搭建高性能可扩展的业务应用,提升运营效率。
INDV vs PRGS — 直观对比
营收规模更大
INDV
是对方的1.4倍
$252.7M
净利率更高
INDV
高出18.7%
10.2%
自由现金流更多
PRGS
多$304.9M
$-245.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $357.0M | $252.7M |
| 净利润 | $103.0M | $25.7M |
| 毛利率 | 82.1% | 81.6% |
| 营业利润率 | 22.7% | 15.2% |
| 净利率 | 28.9% | 10.2% |
| 营收同比 | — | 17.5% |
| 净利润同比 | 390.5% | 2144.6% |
| 每股收益(稀释后) | $0.79 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
INDV
PRGS
| Q4 25 | $357.0M | $252.7M | ||
| Q3 25 | $314.0M | $249.8M | ||
| Q2 25 | $302.0M | $237.4M | ||
| Q1 25 | $266.0M | $238.0M | ||
| Q4 24 | — | $215.0M | ||
| Q3 24 | $307.0M | $178.7M | ||
| Q2 24 | $299.0M | $175.1M | ||
| Q1 24 | — | $184.7M |
净利润
INDV
PRGS
| Q4 25 | $103.0M | $25.7M | ||
| Q3 25 | $42.0M | $19.4M | ||
| Q2 25 | $18.0M | $17.0M | ||
| Q1 25 | $47.0M | $10.9M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $22.0M | $28.5M | ||
| Q2 24 | $-97.0M | $16.2M | ||
| Q1 24 | — | $22.6M |
毛利率
INDV
PRGS
| Q4 25 | 82.1% | 81.6% | ||
| Q3 25 | 73.2% | 81.0% | ||
| Q2 25 | 82.8% | 80.1% | ||
| Q1 25 | 83.1% | 80.6% | ||
| Q4 24 | — | 83.0% | ||
| Q3 24 | 78.5% | 83.7% | ||
| Q2 24 | 73.6% | 81.7% | ||
| Q1 24 | — | 82.2% |
营业利润率
INDV
PRGS
| Q4 25 | 22.7% | 15.2% | ||
| Q3 25 | 13.7% | 17.6% | ||
| Q2 25 | 23.8% | 16.3% | ||
| Q1 25 | 24.8% | 13.6% | ||
| Q4 24 | — | 10.0% | ||
| Q3 24 | 11.4% | 22.6% | ||
| Q2 24 | -39.5% | 15.5% | ||
| Q1 24 | — | 19.0% |
净利率
INDV
PRGS
| Q4 25 | 28.9% | 10.2% | ||
| Q3 25 | 13.4% | 7.8% | ||
| Q2 25 | 6.0% | 7.2% | ||
| Q1 25 | 17.7% | 4.6% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | 7.2% | 15.9% | ||
| Q2 24 | -32.4% | 9.2% | ||
| Q1 24 | — | 12.3% |
每股收益(稀释后)
INDV
PRGS
| Q4 25 | $0.79 | $0.59 | ||
| Q3 25 | $0.33 | $0.44 | ||
| Q2 25 | $0.14 | $0.39 | ||
| Q1 25 | $0.38 | $0.24 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $0.16 | $0.65 | ||
| Q2 24 | $-0.72 | $0.37 | ||
| Q1 24 | — | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $195.0M | $94.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $-98.0M | $478.3M |
| 总资产 | $1.2B | $2.5B |
| 负债/权益比越低杠杆越低 | — | 2.93× |
8季度趋势,按日历期对齐
现金及短期投资
INDV
PRGS
| Q4 25 | $195.0M | $94.8M | ||
| Q3 25 | $445.0M | $99.0M | ||
| Q2 25 | $510.0M | $102.0M | ||
| Q1 25 | $373.0M | $124.2M | ||
| Q4 24 | — | $118.1M | ||
| Q3 24 | — | $232.7M | ||
| Q2 24 | — | $190.4M | ||
| Q1 24 | — | $133.2M |
总债务
INDV
PRGS
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
INDV
PRGS
| Q4 25 | $-98.0M | $478.3M | ||
| Q3 25 | $-207.0M | $477.7M | ||
| Q2 25 | $-257.0M | $452.7M | ||
| Q1 25 | $-285.0M | $431.8M | ||
| Q4 24 | — | $438.8M | ||
| Q3 24 | $-310.0M | $425.6M | ||
| Q2 24 | $-281.0M | $401.7M | ||
| Q1 24 | — | $461.7M |
总资产
INDV
PRGS
| Q4 25 | $1.2B | $2.5B | ||
| Q3 25 | $1.4B | $2.4B | ||
| Q2 25 | $1.5B | $2.4B | ||
| Q1 25 | $1.4B | $2.5B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.6B | ||
| Q1 24 | — | $1.5B |
负债/权益比
INDV
PRGS
| Q4 25 | — | 2.93× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 3.22× | ||
| Q1 25 | — | 3.50× | ||
| Q4 24 | — | 3.48× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-221.0M | $62.8M |
| 自由现金流经营现金流 - 资本支出 | $-245.0M | $59.9M |
| 自由现金流率自由现金流/营收 | -68.6% | 23.7% |
| 资本支出强度资本支出/营收 | 6.7% | 1.1% |
| 现金转化率经营现金流/净利润 | -2.15× | 2.44× |
| 过去12个月自由现金流最近4个季度 | $-93.0M | $229.5M |
8季度趋势,按日历期对齐
经营现金流
INDV
PRGS
| Q4 25 | $-221.0M | $62.8M | ||
| Q3 25 | $-39.0M | $73.4M | ||
| Q2 25 | $158.0M | $30.0M | ||
| Q1 25 | $75.0M | $68.9M | ||
| Q4 24 | — | $19.7M | ||
| Q3 24 | $2.0M | $57.7M | ||
| Q2 24 | $88.0M | $63.7M | ||
| Q1 24 | — | $70.5M |
自由现金流
INDV
PRGS
| Q4 25 | $-245.0M | $59.9M | ||
| Q3 25 | $-59.0M | $72.4M | ||
| Q2 25 | $141.0M | $29.5M | ||
| Q1 25 | $70.0M | $67.7M | ||
| Q4 24 | — | $16.8M | ||
| Q3 24 | $-5.0M | $56.6M | ||
| Q2 24 | $84.0M | $62.7M | ||
| Q1 24 | — | $70.2M |
自由现金流率
INDV
PRGS
| Q4 25 | -68.6% | 23.7% | ||
| Q3 25 | -18.8% | 29.0% | ||
| Q2 25 | 46.7% | 12.4% | ||
| Q1 25 | 26.3% | 28.4% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | -1.6% | 31.7% | ||
| Q2 24 | 28.1% | 35.8% | ||
| Q1 24 | — | 38.0% |
资本支出强度
INDV
PRGS
| Q4 25 | 6.7% | 1.1% | ||
| Q3 25 | 6.4% | 0.4% | ||
| Q2 25 | 5.6% | 0.2% | ||
| Q1 25 | 1.9% | 0.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | 2.3% | 0.6% | ||
| Q2 24 | 1.3% | 0.5% | ||
| Q1 24 | — | 0.2% |
现金转化率
INDV
PRGS
| Q4 25 | -2.15× | 2.44× | ||
| Q3 25 | -0.93× | 3.78× | ||
| Q2 25 | 8.78× | 1.76× | ||
| Q1 25 | 1.60× | 6.30× | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | 0.09× | 2.03× | ||
| Q2 24 | — | 3.93× | ||
| Q1 24 | — | 3.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
PRGS
| Maintenanceand Services | $187.5M | 74% |
| Share File Acquisition | $67.5M | 27% |